Medicine
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc 400 units/3.5 mg/10000 units per g eye ointment
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc 400 units/3.5 mg/10000 units per g eye ointment is a prescription medicine containing Bacitracin zinc, Neomycin and Polymyxin b for ophthalmic use, marketed by Bausch & Lomb, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 15°C to 25°C (59°F to 77°F).
Key facts
- Active ingredient (INN)
- Bacitracin zinc, Neomycin and Polymyxin b
- Brand
- Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
- Strength
- 400 units/3.5 mg/10000 units per g
- Dosage form
- Eye ointment
- Route
- Ophthalmic
- Packs
- 1 tube
- Marketing authorisation holder
- Bausch & Lomb
- Manufacturer
- Bausch & Lomb
- Origin register
- US FDA, United States
- Storage
- Store between 15°C to 25°C (59°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 October 1995
- Identifiers
- RxCUI 308493DailyMed set ID f3231f1c-665e-4efa-baa1-83bf296b2f8fNDC 24208-780Application ANDA064064
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 3.5 g in 1 tube | 24208-780-55 | Bausch & Lomb | 30 October 1995 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 May 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Bacitracin zinc, Neomycin and Polymyxin b is a fixed-dose combination of an aminoglycoside antibacterial and a polymyxin-class antibacterial. It is available as eye ointment for ophthalmic use. MedsAcross supplies Bacitracin zinc, Neomycin and Polymyxin b for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Bacitracin zinc, Neomycin and Polymyxin bFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Neomycin and Polymyxin B Sulfates and Bacitracin Zinc prescribing information (Bausch & Lomb) · U.S. National Library of Medicine, DailyMed
Need Neomycin and Polymyxin B Sulfates and Bacitracin Zinc 400 units/3.5 mg/10000 units per g eye ointment for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.